Back to All Topics
Mitochondrial
Research Article
2 min read
SS-31 Cardiolipin Binding
How SS-31 targets the inner mitochondrial membrane through cardiolipin binding.
Introduction
SS-31 (Elamipretide) uniquely targets mitochondria through cardiolipin binding.
Cardiolipin Basics
Structure and Function
| Feature | Description |
|---|---|
| Location | Inner mitochondrial membrane |
| Structure | Phospholipid, 4 fatty acid chains |
| Function | Electron transport chain support |
| Importance | Energy production critical |
Role in Mitochondria
| Function | Significance |
|---|---|
| ETC organization | Complex stability |
| Cytochrome c binding | Electron transfer |
| Cristae structure | Membrane organization |
| ATP synthesis | Energy production |
SS-31 Mechanism
Cardiolipin Interaction
| Step | Event | Outcome |
|---|---|---|
| 1 | SS-31 penetrates cell | Mitochondrial targeting |
| 2 | Binds cardiolipin | Stabilization |
| 3 | ETC optimization | Improved function |
| 4 | Reduced ROS | Less oxidative stress |
| 5 | Enhanced ATP | More energy |
Specific Effects
| Effect | Mechanism | Benefit |
|---|---|---|
| ETC efficiency | Cardiolipin stabilization | More ATP/less ROS |
| Membrane integrity | Structural support | Mitochondrial health |
| Cytochrome c retention | Binding maintenance | Reduced apoptosis |
Research Findings
Cellular Studies
| Finding | Significance |
|---|---|
| ROS reduction | Oxidative stress protection |
| ATP increase | Energy enhancement |
| Membrane potential | Maintained function |
| Cardiolipin preservation | Structural benefit |
Disease Models
| Condition | SS-31 Effect | Evidence |
|---|---|---|
| Heart failure | Improved function | Phase 2 trials |
| Mitochondrial myopathy | Symptom improvement | Case studies |
| Aging | Potential benefit | Animal data |
| Ischemia-reperfusion | Protection | Strong |
Applications in Performance
Potential Benefits
| Application | Mechanism | Status |
|---|---|---|
| Endurance | ATP production | Theoretical |
| Recovery | Cellular energy | Theoretical |
| Aging athletes | Mitochondrial support | Speculative |
| Cardiac function | Heart efficiency | Research |
Practical Considerations
| Factor | Reality |
|---|---|
| Availability | Research/clinical only |
| Dosing | Clinical trial protocols |
| Evidence | Strongest for medical uses |
| Performance use | Unvalidated |
Conclusion
SS-31's cardiolipin binding offers unique mitochondrial support mechanism.
Stay Updated on Peptide Research
Get weekly breakdowns of new studies, dosing insights, and community protocols. No spam, unsubscribe anytime.